It was at an MM&M event back in late 2013 that I got my first glimpse of how this industry feels about big data.
Fueled by system-wide demand and facilitated by AI, the industry’s lofty expectations around real-world evidence could soon be fulfilled
FDA Commissioner Dr. Scott Gottlieb has been saying all the right things regarding digital health.
Strategies for differentiating CAR-T therapies emerge in the early days of 2018, while competitors race to catch up with Novartis and Gilead.
Sigurdsson is charged with leading the agency’s digital offering to meet growing client demand.
Rather than talking at them, we need to design with and for them.
The VP of market access at Mitsubishi Tanabe Pharma America discusses driving access and bringing to market the first FDA-approved ALS drug in years.
Get the most out of
Register for free and enjoy unlimited access to: